) - Technical Bulletin
CF770, Succinimidyl Ester
Catalog Number SCJ4600060
Storage Temperature –20 °C
TECHNICAL BULLETIN
Product Description
CF770, succinimidyl ester (CF770 SE) is used
(1999) 89:759-770.
16. Cell Tissue Research (1999) 297:409-421.
17. Rymar, V. et al., J. Comparative Neurology (2004) 469:325-339.
18. Manaye, K. et al., Neuroscience (1999) 89: 759-770.
Anticoagulant J. Clin. Pathol., 30,
766 (1977).
4. Concise Encyclopedia Biochemistry, 2nd ed.,
Scott, T., and Eagleson, M., Walter de Gruyter
(New York, NY: 1988) p. 117.
MES/RXR 9/03
Sigma
solido selettivo per la ricerca di Salmonella sp. in prodotti
lattiero-caseari., II latte, 7/93, 770
7. C. Cantoni, et at., Comparazione tra vari terreni selettivi per l'isolamento di salmonella sp
solido selettivo per la ricerca di Salmonella
sp. in prodotti lattiero-caseari., II latte, 7/93, 770
7. C. Cantoni, et at., Comparazione tra vari terreni selettivi per l'isolamento di salmonella sp
A., et al., Biol. Cell, 63, 319-326 (1988).
5. Shlomai, A., and Shaul, Y., Hepatology, 37, 764-
770 (2003).
6. Vent, J., et al., J. Cell. Sci., 118, 4333-4341 (2005).
7. Soroka, C.J., et
region domain.
Oncogene, 9, 1745-1750 (1994).
2. Chadee, D.N. et al., MLK3 is required for mitogen
activation of B-Raf, ERK and cell proliferation.
Nature Cell Biol., 6, 770-776 (2004).
PRECISIO
D.C., 76, 1972.
7. Supplier Information
8. Martindale, The Extra Pharmacopoeia, 30th ed., 770, 1993.
9. Ponzoni, M. and Lanciotti, M.J., Neurochem. 54, 540, 1990.
10. Meyskens, F.L., Jr. and Fuller
glycerol.
Molecular mass: ∼57 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 569–770 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
mutations in
patients with features of Marfan syndrome and
Loeys-Dietz syndrome. Hum. Mutat., 27, 770-777
(2006).
2. Larsson, J. et al., Abnormal angiogenesis but intact
hematopoietic potential in
Academy of
Sciences, Washington, D.C., 76, 1972.
3. Martindale, The Extra Pharmacopoeia, 30th ed.,
770, 1993.
4. Ponzoni, M. and Lanciotti, M.J., Neurochem. 54,
540, 1990.
5. Meyskens, F.L.
vortexing the Labeling Solution,
add 30–50 µL of the 10 mM Dye Stock Solution in a
dropwise fashion. The 30–50 µL volume
corresponds to a dye:protein molar ratio of 9:1 to
15:1. As stated earlier, the
puberty. J. Neuroendocrino., 22(7), 765-770
(2010).
3. Page, N.M., Neurokinin B and pre-eclampsia: a
decade of discovery. Reprod. Biol. Endocrinol., 8,
4-9 (2010).